Skip to main content
. 2010 Sep;21(9):1587–1596. doi: 10.1681/ASN.2009111109

Table 3.

Frequencies and incidence rates of SAEs that occurred in two or more patients in any group by category

Parameter Belatacept
CsA
% (n = 102) Incidence Rate/100 patient-years (95% CI) % (n = 26) Incidence Rate/100 patient-years (95% CI)
Infections to total 16 4.0 (2.3 to 6.5) 27 7.1 (2.8 to 14.6)
    UTI 4 1.0 (0.3 to 2.6) 12 3.4 (0.7 to 9.9)
    pneumonia 3 0.8 (0.2 to 2.2) 0 0.0 (0.0 to 3.7)
    pyelonephritis 2 0.5 (0.1 to 1.8) 4 1.0 (0.0 to 5.7)
    gastroenteritis 2 0.5 (0.1 to 1.8) 4 1.1 (0.0 to 5.9)
Neoplasms to total 12 3.0 (1.5 to 5.2) 12 3.0 (0.6 to 8.9)
    basal cell carcinoma 4 1.0 (0.3 to 2.6) 4 1.0 (0.0 to 5.8)
    squamous cell carcinoma 2 0.5 (0.1 to 1.8) 4 1.0 (0.0 to 5.7)
    breast cancer 2 0.5 (0.1 to 1.8) 0 0.0 (0.0 to 3.7)
Gastrointestinal disorders to total 12 3.0 (1.5 to 5.2) 8 2.0 (0.2 to 7.3)
    diarrhea 4 1.0 (0.3 to 2.6) 4 1.0 (0.0 to 5.8)
    abdominal pain 2 0.5 (0.1 to 1.8) 0 0.0 (0.0 to 3.7)
    pancreatitis 2 0.5 (0.1 to 1.8) 0 0.0 (0.0 to 3.7)
General disorders to total 3 0.7 (0.2 to 2.2) 4 1.0 (0.0 to 5.6)
    pyrexia 2 0.5 (0.1 to 1.8) 4 1.0 (0.0 to 5.8)
Cardiac disorders to total 2 0.5 (0.1 to 1.8) 12 3.0 (0.6 to 8.9)
    coronary artery stenosis 0 0.0 (0.0 to 0.9) 8 2.1 (0.3 to 7.5)

CI, confidence interval.